SEC Form 4/A · accession 0001179022-19-000023
GALECTIN THERAPEUTICS INC · GALT
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
This is an amendment (Form 4/A). It replaces an earlier filing for the same period.
Reporting owner
Richard E Uihlein
Director · 10% Owner
Period of report
Jan 28, 2019
Accepted (ET)
Jan 31, 2019 · 10:55 am EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001133416
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1,F3 | Jan 28, 2019 | P | 3,000 | $4.7717 | A | 2,538,289 | D | |
| Common StockF2,F3 | Jan 29, 2019 | P | 48,500 | $4.871 | A | 2,586,789 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The shares were purchased in multiple transactions at prices ranging from $4.77 to $4.78. This amount represents the weighted average purchase price of such transactions. The reporting person undertakes to provide full information regarding the number of shares purchased at each separate price upon request by the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer.
- F2The shares were purchased in multiple transactions at prices ranging from $4.75 to $5.00. This amount represents the weighted average purchase price of such transactions. The reporting person undertakes to provide full information regarding the number of shares purchased at each separate price upon request by the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer.
- F3This Form 4 is being amended to correct footnotes (1) and (2) for the purchase transactions on January 28, 2019 and January 29, 2019, which footnotes incorrectly stated that the shares were sold in multiple transactions, but should have stated that the shares were purchased in multiple transactions.